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With prostate and colorectal malignancies being the most common cancers in men, elevated prostate
speciﬁc antigen (PSA) in patients without rectal access due to prior surgery poses a diagnostic dilemma.
We report the ﬁrst use of CT-guided biopsy in combination with prebiopsy MRI in 2 patients with a
clinical suspicion of prostate cancer and no rectal access. In both cases, a diagnostic multiparametric MRI
of the prostate was performed to detect and to localize a potential suspicious lesion. The localization
served as a cognitive map for guiding needle placement using a CT-guided transgluteal approach.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Prostate and colorectal malignancies are among the most
common cancers in men, therefore it is not uncommon to
encounter patients with synchronous or metachronous disease.
Abdomino-perineal resection (APR) is a common surgical tech-
nique performed in patients with rectal cancer and additionally
may be offered prophylactically in high risk patients with inherited
colorectal syndromes, or as a treatment option for inﬂammatory
bowel disease. APR completely removes the distal colon, rectum,
and anal sphincter complex using both anterior abdominal and
perineal incisions, resulting in a permanent colostomy.1 Digital
rectal examination (DRE) and transrectal ultrasound-guided
(TRUS) prostate biopsy remain the current standard approach for
diagnosing suspected prostate cancer, with histopathologic tissue
evaluation considered essential before commencement of treat-
ment.3 Both require rectal access, thus elevated prostate speciﬁc
antigen (PSA) in patients without rectal access due to prior surgery
poses a diagnostic dilemma.
To date, different approaches have been described for such
patients in the literature, including systematic biopsy sampling via
an ultrasound-guided transperineal approach, or a transglutealbe Way, Cambridge, CB2 0AE,
(I. Caglic).
Inc. This is an open access article uroute under the guidance of CT or MRI, respectively.2,3 To our
knowledge, however, there is only one case report describing
targeted biopsy, using MRI and a transgluteal approach.4 We
report on two patients presenting to our department with a raised
PSA following rectal surgery where lesion-targeted CT-guided
transgluteal biopsy was employed to achieve a diagnosis of pros-
tate cancer.Case presentation
Patient 1, 63-year-old man, presenting with a rising PSA of
18.3 ng/mL, 7 years post neoadjuvant chemotherapy and resection
of rectum for pT3N0M0 rectal cancer. Patient 2, a 69-year-old man
presenting with PSA 10.2 ng/mL, 1 year following APR for pT2N0M0
rectal cancer.Prebiopsy MRI
Prebiopsy multiparametric 3T MRI of the prostate was per-
formed incorporating T2-weighted, diffusion-weighted imaging
(b-values 50, 400, 1000), and dynamic contrast-enhanced se-
quences. Images revealed highly suspicious lesions in the right base
peripheral zone in patient 1 (Fig. 1) and in the right mid peripheral
zone in patient 2 (Fig. 2). The MR images served as a cognitive map
for subsequently directing the biopsy.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Patient 1. High probability MRI target and targeted CT-guided transgluteal biopsy. a-c: MRI demonstrates a high probability 16  12 mm lesion at the posterior right base
peripheral zone with low T2 signal intensity (a), restricted diffusion with low ADC value (b) and an early enhancement pattern on a DCE color map (c). d: CT image of a patient in a
prone position with a radiopaque grid applied. Note the thickening and stenosis of the rectum wall. e: CT image of transgluteal biopsy needle guided to this region.
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Written consent was obtained. Patients followed a standard
CT-guided biopsy protocol, with biopsies performed in the prone
position. No prophylactic antibiotics were administered as the
needle was not expected to pass via the rectum. The procedure was
conducted by an experienced interventional radiologist, in coop-
eration with a uro-radiologist to ensure the optimal cognitive
fusion. A single-puncture percutaneous transgluteal approach wasFigure 2. Patient 2.HighprobabilityMRI target and targetedCT-guided transgluteal biopsy. a:M
gland peripheral zone shows low T2 signal intensity. b: CT image of transgluteal biopsy needleused, with an aseptic technique and 1% lidocaine as local anes-
thesia. A Chiba co-axial needle (Cook Medical, Bloomington, IN,
USA) was introduced under direct CT guidance and cognitively
positioned to the target point in the prostate. Four biopsy speci-
mens were taken through coaxial needle system using 22 mm, 18G
Bard Magnum (Bard biopsy systems, Tempe, AZ, USA). After
acquiring the ﬁrst sample the trocar was tilted slightly for subse-
quent passes to ensure a larger sample area. Tissue samples were
sent for histopathological examination. A post-biopsy CT of pelvisRT2w image demonstrates a highprobability 2010mmlesion at theposterior rightmid-
guided to this region. Note the absence of rectum between the prostate and the sacrum.
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were well tolerated, with an overall procedure time was approxi-
mately 15 min, and both patients being discharged 3 h post-
procedure.
Results
Both biopsies were positive for prostatic adenocarcinoma, pa-
tient 1: Gleason Grade 4 þ 3 ¼ 7 in 4/4 cores involving up to 50%;
patient 2: Gleason Grade 3 þ 5 ¼ 8 in 4/4 cores, with total surface
area involved 70%.
Discussion
Patients with previous APR and suspected prostate cancer
require a different diagnostic approach due to the lack of rectal
access.We report a lesion-targeted CT-guided transgluteal biopsy of
the prostate following prebiopsyMRI. In our two cases it has proven
to be a safe and reliable diagnostic approach with high detection
rate in selected patients without rectal access.
Various approaches to this diagnostic dilemma have been pre-
viously described and the decision on which to use may in part
depend on the local experience and the type of equipment avail-
able. Prostate punctures are performed by urologists in our insti-
tution, exclusively by under TRUS guidance. The equipment
required to perform more sophisticated in-bore MRI-guided
punctures is not available. The axial imaging planes of MRI and CT
are almost identical, making orientation/cognitive fusion straight-
forward and reliable in the hands of an experienced radiologist.
Given this, and considering the local experience, a lesion-targeted
CT-guided biopsy with transgluteal approach was chosen.
A number of recent studies have suggested that targeted sam-
pling of prostate lesions identiﬁed by MRI yields better results than
systematic biopsies alone. Conversely, a recent large prospective
study showed that combining systematic biopsy to targeted cores
does not necessarily improve biopsy yields.5 We therefore decided
to acquired targeted cores alone, using one entry site with four
cores only which was less invasive and well tolerated by the pa-
tients. Additionally, this approach allowed us to perform the pro-
cedure under local anesthesia cover.The histopathology results conﬁrmed a high success rate, with
all 8 biopsy cores positive for cancer. However, it is worth empha-
sizing that both index lesions measured >15 mm, which may have
helped to minimize the risk of targeting error. In order to calculate
the true sensitivity and accuracy, and to evaluate the cost-beneﬁt of
this diagnostic method, larger studies or data from multicentric
studies would be required. One drawback of this technique is the
radiation exposure, however, the alternative approaches using a
transperineal US-guided approach or in-bore MRI-guidance entail
their own disadvantages.
We believe that the described method is feasible and could be
quickly applied at almost no extra cost in hospitals that are already
performing CT-guided procedures but lack state of the art MRI
compatible biopsy devices.Conclusion
To our knowledge, this is the ﬁrst report of lesion-targeted CT-
guided transgluteal biopsy of prostate in combination with pre-
biopsy MRI. In our two cases it has proven to be a safe approach
with a high diagnostic yield.Conﬂict of interest
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